1,721,247 research outputs found
Prevenzione della trasmissione materno-fetale di HIV in zon rurale: dai trials all’esperienza sul campo
No full textAtti del Congresso, pag 14
Is the time for an AIDS-free new generation different in resource-limited and industrialized countries?
No full text[No abstract available
Positive Results of Immunoglobulin G Cytomegalovirus Serologic Testing and Risk of Severe Non-AIDS-Related Complications in HIV-Infected Patients Reply
No full textLONG TERM VAGINAL ADMINISTRATION OF LACTOBACILLUS RHAMNOSUS AS COMPLEMENTARY APPROACH TO MANAGEMENT OF BACTERIAL VAGINOSIS
No full text
Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia
No full textQuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis
No full textRecently, a simple whole blood test, QuantiFERON-TB Gold (QFT-Gold), has been adopted for immunologic diagnosis of Mycobacterium tuberculosis infection. A total of 369 individuals with suspected tuberculosis (TB) were tested with the QFT-Gold, whereas a subgroup of 62 patients was tested simultaneously with QFT-Gold test and an assay based on selected peptides from early secreted antigenic target 6 and culture filtrate protein 10 proteins. The sensitivity of the QFT-Gold assay for active TB was 72.9%, and the agreement between this test and tuberculin skin test was 75%. Using selected peptides, we found a positive response in the majority of active TB patients, with a sensitivity of 84% and a specificity of 89%. Our study suggests the usefulness of QFT-Gold in routine clinical practice on unselected patients with suspected TB. Moreover, the assay based on selected peptides is a useful tool to discriminate between active and latent TB and shows a high predictive value. (C) 2008 Elsevier Inc. All rights reserved
Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression.
No full text- …
